Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-12-069617
Filing Date
2012-10-17
Accepted
2012-10-17 15:09:04
Documents
4
Group Members
HARRI V. TARANTOMARK KESSELSYMPHONY CAPITAL GP, L.P.SYMPHONY GP, LLCSYMPHONY STRATEGIC PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-24364_1sc13da.htm SC 13D/A 221267
2 EX-1 a12-24364_1ex1.htm EX-1 43642
3 EX-3 a12-24364_1ex3.htm EX-3 192290
4 GRAPHIC g243641kg01i001.jpg GRAPHIC 2147
  Complete submission text file 0001104659-12-069617.txt   461986
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80035 | Film No.: 121148272
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYMPHONY CAPITAL LLC 875 THIRD AVENUE NEW YORK NY 10022
Business Address C/O SYMPHONY CAPITAL LLC 875 THIRD AVENUE NEW YORK NY 10022 212-632-5400
Symphony Capital Partners LP (Filed by) CIK: 0001296059 (see all company filings)

EIN.: 000000000
Type: SC 13D/A